4//SEC Filing
Glenn Gregory M 4
Accession 0001209191-22-018657
CIK 0001000694other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 7:45 PM ET
Size
8.2 KB
Accession
0001209191-22-018657
Insider Transaction Report
Form 4
NOVAVAX INCNVAX
Glenn Gregory M
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-10+28,341→ 28,341 totalExercise: $77.77Exp: 2032-03-10→ Common Stock (28,341 underlying) - Award
Restricted Stock Units
2022-03-10+18,894→ 18,894 total→ Common Stock (18,894 underlying)
Footnotes (3)
- [F1]Twenty-five percent (25%) of the shares subject to this option grant under the Novavax, Inc. (the "Company") Amended and Restated 2015 Stock Incentive Plan, as amended (the "Plan"), will vest on the first anniversary of the March 10, 2022 grant date (the "Grant Date"), and the remaining seventy-five percent (75%) of the shares will vest in equal monthly installments over the following three (3) years, in each case subject to continued employment through such vesting date.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Company's common stock.
- [F3]One-third (1/3) of the RSUs subject to this grant under the Plan will vest on each of the first three (3) anniversaries of the Grant Date, in each case subject to continued employment through such vesting date.
Documents
Issuer
NOVAVAX INC
CIK 0001000694
Entity typeother
Related Parties
1- filerCIK 0001342823
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 7:45 PM ET
- Size
- 8.2 KB